Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0000899243-20-009976)

Filing Details

Accession Number:
0000899243-20-009976
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-02 15:30:39
Reporting Period:
2020-03-31
Accepted Time:
2020-04-02 15:30:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1061027 Sunesis Pharmaceuticals Inc SNSS Pharmaceutical Preparations (2834) 943295878
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1724190 P. William Quinn Sunesis Pharmaceuticals, Inc.
395 Oyster Point Boulevard, Ste. 400
South San Francisco CA 94080		 See Remarks No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-31 6,000 $0.65 121,697 No 4 P Direct
Common Stock Acquisiton 2019-11-29 6,000 $0.37 127,697 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2020-03-31 360,000 $0.00 360,000 $0.41
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
360,000 2030-03-31 No 4 A Direct
Footnotes
  1. Shares acquired under the Issuer's stock purchase plan.
  2. One fourth (1/4th) of the shares shall vest one (1) year from the Vesting Commencement Date of March 31, 2020. Thereafter, one forty-eighth (1/48th) of shares granted shall vest monthly over the next thirty-six (36) months.